Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-25 @ 5:01 PM
Study NCT ID:
NCT00838903
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2009-02-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2012-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-05
First Submit QC Date:
None
Study First Post Date:
2009-02-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-04-17
Results First Submit QC Date:
None
Results First Post Date:
2014-05-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-18
Last Update Post Date:
2017-01-09
Last Update Post Date Type:
ESTIMATED